Physician profile
Darius D Divina
NPI 1366544843
$5,279.33
in general payments reported to CMS, 2019-2025
28 companies · $491 in 2025
The $491 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $2,385 · 2021: $183 · 2022: $383 · 2023: $428 · 2024: $417 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,335.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,271.36 | 2019-2020 | |
| Stryker Corporation | $983.97 | 2021-2025 | Mako, Triathlon, Tornier Perform Reversed Augmented Glenoid |
| Southtech Orthopedics | $645.00 | 2019 | |
| Si-Bone, INC. | $195.69 | 2022-2024 | |
| Ferring Pharmaceuticals INC. | $175.60 | 2019-2025 | Euflexxa |
| Amgen INC. | $132.44 | 2020-2025 | Krystexxa, Evenity, Prolia |
| Bioventus LLC | $130.73 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $126.73 | 2025 | Eterna |
| Innovation Technologies INC | $84.00 | 2019 | |
| Baudax Bio INC. | $76.08 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $60.93 | 2023 | Seglentis |
| Protega Pharmaceutials INC | $51.60 | 2025 | Roxybond |
| Medacta USA, INC. | $46.53 | 2019 | |
| Endo USA, INC. | $41.64 | 2024 | Xiaflex |
| Wright Medical Technology, INC. | $35.24 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.78 | 2021 | |
| Fidia Pharma USA INC. | $26.94 | 2020-2023 | Hymovis, Triluron |
| Medtronic, INC. | $22.48 | 2024 | Intellis Adaptivestim |
| Ethicon US, LLC | $20.64 | 2022 | |
| Trice Medical, INC. | $16.88 | 2024 | |
| Pacira Therapeutics, INC. | $15.90 | 2019 | |
| Teleflex LLC | $14.22 | 2022 | |
| Pfizer INC. | $14.04 | 2019 | |
| Avanos Medical | $12.92 | 2019 | |
| Molnlycke Health Care US, LLC | $12.76 | 2019 | |
| Breg, INC | $12.24 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $11.81 | 2022 | |
| Heraeus Medical, LLC. | $10.18 | 2025 | Palacos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darius Divina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.